A Fytagoridis1, P Blomstedt. 1. Department of Neurosurgery, University Hospital of Northern Sweden, Umeå, Sweden. anders.fytagoridis @ neuro.umu.se
Abstract
BACKGROUND: The posterior subthalamic area (PSA), including the zona incerta and prelemniscal radiation (Raprl), has recently been presented in number of publications as a promising target for deep brain stimulation (DBS) in the treatment of various movement disorders. In order to evaluate the safety of the procedure, we analyzed our initial 40 patients for complications and side effects. METHODS: 40 patients treated with PSA DBS for Parkinson's disease, essential tremor and other forms of tremor were included. RESULTS: The most severe complication was 1 transient mild hemiparesis and 1 infection. Minor complications and side effects were relatively frequent, including mild transient dysphasia in 22.5% of the patients. CONCLUSIONS: Few serious complications were encountered, and we consider the PSA to be a safe target for DBS. (c) 2010 S. Karger AG, Basel.
BACKGROUND: The posterior subthalamic area (PSA), including the zona incerta and prelemniscal radiation (Raprl), has recently been presented in number of publications as a promising target for deep brain stimulation (DBS) in the treatment of various movement disorders. In order to evaluate the safety of the procedure, we analyzed our initial 40 patients for complications and side effects. METHODS: 40 patients treated with PSA DBS for Parkinson's disease, essential tremor and other forms of tremor were included. RESULTS: The most severe complication was 1 transient mild hemiparesis and 1 infection. Minor complications and side effects were relatively frequent, including mild transient dysphasia in 22.5% of the patients. CONCLUSIONS: Few serious complications were encountered, and we consider the PSA to be a safe target for DBS. (c) 2010 S. Karger AG, Basel.
Authors: Jonathan Jagid; Karthik Madhavan; Amade Bregy; Mehul Desai; Armando Ruiz; Robert Quencer; Howard J Landy Journal: BMJ Case Rep Date: 2015-10-16
Authors: M Lefranc; M Manto; P Merle; M Tir; D Montpellier; J-M Constant; D Le Gars; J-M Macron; P Krystkowiak Journal: Cerebellum Date: 2014-06 Impact factor: 3.847
Authors: Gavin J B Elias; Aaron Loh; Dave Gwun; Aditya Pancholi; Alexandre Boutet; Clemens Neudorfer; Jürgen Germann; Andrew Namasivayam; Robert Gramer; Michelle Paff; Andres M Lozano Journal: Brain Date: 2021-04-12 Impact factor: 13.501
Authors: Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang Journal: Front Neurol Date: 2021-06-09 Impact factor: 4.003
Authors: Michael T Barbe; Jeremy Franklin; Daria Kraus; Paul Reker; Till A Dembek; Niels Allert; Jochen Wirths; Jürgen Voges; Lars Timmermann; Veerle Visser-Vandewalle Journal: Trials Date: 2016-09-29 Impact factor: 2.279